These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19958824)

  • 21. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
    Shahbazi MA; Hamidi M; Mohammadi-Samani S
    J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin.
    Mao S; Bakowsky U; Jintapattanakit A; Kissel T
    J Pharm Sci; 2006 May; 95(5):1035-48. PubMed ID: 16565978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
    Gan Q; Wang T; Cochrane C; McCarron P
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicochemical and pharmacological characterization of alpha-tocopherol-loaded nano-emulsion system.
    Hatanaka J; Chikamori H; Sato H; Uchida S; Debari K; Onoue S; Yamada S
    Int J Pharm; 2010 Aug; 396(1-2):188-93. PubMed ID: 20558261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen.
    Hassani Najafabadi A; Abdouss M; Faghihi S
    Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():91-9. PubMed ID: 24907742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs.
    Duhem N; Rolland J; Riva R; Guillet P; Schumers JM; Jérome C; Gohy JF; Préat V
    Int J Pharm; 2012 Feb; 423(2):452-60. PubMed ID: 22212463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles.
    Yoncheva K; Guembe L; Campanero MA; Irache JM
    Int J Pharm; 2007 Apr; 334(1-2):156-65. PubMed ID: 17118588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
    Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
    Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats.
    Anwar M; Warsi MH; Mallick N; Akhter S; Gahoi S; Jain GK; Talegaonkar S; Ahmad FJ; Khar RK
    Eur J Pharm Sci; 2011 Oct; 44(3):241-9. PubMed ID: 21864678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.
    Bravo-Osuna I; Schmitz T; Bernkop-Schnürch A; Vauthier C; Ponchel G
    Int J Pharm; 2006 Jun; 316(1-2):170-5. PubMed ID: 16580797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural polyampholyte-based core-shell nanoparticles with N-carboxyethylchitosan-containing core and poly(ethylene oxide) shell.
    Mincheva R; Bougard F; Paneva D; Vachaudez M; Manolova N; Rashkov I; Dubois P
    Biomacromolecules; 2009 Apr; 10(4):838-44. PubMed ID: 19235933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
    Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
    Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
    Kafedjiiski K; Hoffer M; Werle M; Bernkop-Schnürch A
    Biomaterials; 2006 Jan; 27(1):127-35. PubMed ID: 16045983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
    Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
    Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
    van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
    Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
    Qiang F; Shin HJ; Lee BJ; Han HK
    Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
    Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
    Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.